Cargando…

Small molecule inhibition of CBP/catenin interactions eliminates drug resistant clones in acute lymphoblastic leukemia

Drug resistance in acute lymphoblastic leukemia (ALL) remains a major problem warranting new treatment strategies. Wnt/catenin signaling is critical for the self-renewal of normal hematopoietic progenitor cells. Deregulated Wnt signaling is evident in chronic and acute myeloid leukemia, however litt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gang, Eun Ji, Hsieh, Yao-Te, Pham, Jennifer, Zhao, Yi, Nguyen, Cu, Huantes, Sandra, Park, Eugene, Naing, Khatija, Klemm, Lars, Swaminathan, Srividya, Conway, Edward M., Pelus, Louis M., Crispino, John, Mullighan, Charles, McMillan, Michael, Müschen, Markus, Kahn, Michael, Kim, Yong-Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994178/ https://www.ncbi.nlm.nih.gov/pubmed/23728349 http://dx.doi.org/10.1038/onc.2013.169

Ejemplares similares

CBP/Catenin Antagonist Safely Eliminates Drug Resistant Leukemia Initiating Cells
por: Zhao, Yi, et al.
Publicado: (2015)

Infectious origins of childhood leukemia
por: Swaminathan, Srividya, et al.
Publicado: (2015)

Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia
por: Swaminathan, Srividya, et al.
Publicado: (2015)

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2018)

Nuclear receptor/Wnt beta-catenin interactions are regulated via differential CBP/p300 coactivator usage
por: Ono, Masaya, et al.
Publicado: (2018)

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
por: Manegold, Philipp, et al.
Publicado: (2018)

The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300
por: Lukaszewicz, Agnes I., et al.
Publicado: (2019)

Fibroblast Growth Factor Receptor-Mediated Activation of AKT-β-Catenin-CBP Pathway Regulates Survival and Proliferation of Murine Hepatoblasts and Hepatic Tumor Initiating Stem Cells
por: Mavila, Nirmala, et al.
Publicado: (2012)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

BCL6 enables Ph(+) acute lymphoblastic leukemia cells to survive BCR-ABL1 kinase inhibition
por: Duy, Cihangir, et al.
Publicado: (2011)

Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review
por: Srividya, Adinarayanan, et al.
Publicado: (2019)

Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia
por: Buchner, Maike, et al.
Publicado: (2015)

YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway
por: Chang, Bill H, et al.
Publicado: (2015)

Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
por: Iacobucci, Ilaria, et al.
Publicado: (2021)

Evolution of Tumor Clones in Adult Acute Lymphoblastic Leukemia
por: Smirnova, S. Yu., et al.
Publicado: (2016)

Structure of CbpA J-Domain Bound to the Regulatory Protein CbpM Explains Its Specificity and Suggests Evolutionary Link between CbpM and Transcriptional Regulators
por: Sarraf, Naghmeh S., et al.
Publicado: (2014)

Antigen presentation by human autoreactive PLP specific T-cell clones
por: Correale, J., et al.
Publicado: (1994)

Molecular dynamics simulations data of six compounds F3J-BRD4/CBP, EX1-BRD4/CBP, and E2T-BRD4/CBP
por: Wu, Shiliang, et al.
Publicado: (2021)

Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents
por: Chen, Qingjuan, et al.
Publicado: (2022)

Cbp3–Cbp6 interacts with the yeast mitochondrial ribosomal tunnel exit and promotes cytochrome b synthesis and assembly
por: Gruschke, Steffi, et al.
Publicado: (2011)

Cbp3–Cbp6 interacts with the yeast mitochondrial ribosomal tunnel exit and promotes cytochrome b synthesis and assembly
por: Gruschke, Steffi, et al.
Publicado: (2011)

The Cbp3–Cbp6 complex coordinates cytochrome b synthesis with bc(1) complex assembly in yeast mitochondria
por: Gruschke, Steffi, et al.
Publicado: (2012)

Development of resistance to dasatinib in Bcr/Abl-positive acute lymphoblastic leukemia
por: Fei, Fei, et al.
Publicado: (2010)

Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2015)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014)

Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia
por: Hjalgrim, L L, et al.
Publicado: (2002)

Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia
por: Ogana, Heather A., et al.
Publicado: (2023)

Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells
por: Bordonaro, Michael, et al.
Publicado: (2016)

The Transcription Coactivator Cbp Is a Dynamic Component of the Promyelocytic Leukemia Nuclear Body
por: Boisvert, François-Michel, et al.
Publicado: (2001)

The prognostic capacities of CBP and p300 in locally advanced rectal cancer
por: Rühlmann, Felix, et al.
Publicado: (2019)

A DNA repair defect in a radiation-sensitive clone of a human bladder carcinoma cell line.
por: Powell, S. N., et al.
Publicado: (1992)

CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia
por: Ketzer, Franz, et al.
Publicado: (2022)

Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children’s Research Hospital Approach
por: Inaba, Hiroto, et al.
Publicado: (2017)

Curcumin, COX-2, and Protein p300/CBP
por: Jung, Ki Tae, et al.
Publicado: (2014)

Dimeric structure of p300/CBP associated factor
por: Shi, Shasha, et al.
Publicado: (2014)

CBP binding outside of promoters and enhancers in Drosophila melanogaster
por: Philip, Philge, et al.
Publicado: (2015)

Alcohol-Induced Neuroadaptation Is Orchestrated by the Histone Acetyltransferase CBP
por: Ghezzi, Alfredo, et al.
Publicado: (2017)

Correction to Protein Lysine Acetylation by p300/CBP
por: Dancy, Beverley M., et al.
Publicado: (2016)

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
por: Strachowska, Magdalena, et al.
Publicado: (2021)

Nilotinib treatment in mouse models of P190 Bcr/Abl lymphoblastic leukemia
por: Kaur, Pavinder, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ph25uh13dvt1hi5im05v29dms3